According to the World Health Organization (WHO), nearly 65 million people are suffering from chronic obstructive pulmonary diseases (COPDs).
According to the World Health Organization (WHO), nearly 65 million people are suffering from chronic obstructive pulmonary diseases (COPDs). These diseases include emphysema, refractory (severe) asthma, and chronic bronchitis. Development of smart inhalers for management of asthma is essential for improvement of quality of life for patients. Researchers have been conducting studies and found the effectiveness of intelligent inhalers for supporting patients, assisting caregivers, and controlling the conditions. Moreover, government and regulatory bodies are offering clearances for usage of smart caps on these inhalers. The demand for smart inhalers will grow considerably in the coming years. According to the report published by Allied Market Research, the global smart inhalers market is expected to generate $1.11 billion by 2030. Following are some of the activities taking place across the world.
Researchers have been conducting studies to determine the role of smart inhalers in managing respiratory conditions such as asthma. According to the study published by researchers in Pediatrics, sensor-based inhalers can be integrated with the clinical workflows of healthcare providers for effective management of asthma. Researchers from the Northwestern University, UnitedHealth Group, and Ann & Robert H. Lurie Children’s Hospital of Chicago collaborated to identify the benefits of sensor-based inhaler monitoring. The inhalers with Bluetooth sensors can send the data regarding medication and health of patients to physicians for monitoring symptoms. This helps healthcare providers in assisting if the symptoms worsen. This assistance can be provided more rapidly than before. The usage of such sensors will definitely improve the quality of lives for caregivers and patients.
Want to Explore More Statistics and Industry Analysis- https://www.alliedmarketresearch.com/request-sample/1715
Remote patient monitoring is an area of healthcare in which medical professionals can collect data and assist patients without physical visits. As researchers have been exploring benefits of sensors in managing respiratory diseases, medical equipment manufacturing companies have been launching new products that would enable remote monitoring and improve quality of lives for patients.
They have been winning clearance from governing bodies such as the U.S. Food and Drug Administration (FDA). Cognita Labs, a California-based startup, gained clearance for its smart cap for inhalers. This cap, known as CapMedic, is nothing but a sensor. It is placed on the top of an inhaler, and collects data for remote patient monitoring purposes. It transmits audio, visual, and haptic signals to communicate whether the inhaler has been shaken properly and is in upright position to ensure a full dose of medication. These inhalers can be paired with smartphone apps to note down data and send to healthcare professionals. Such clearances from FDA will increase in the coming years as novel devices make their way.